MRK
BalancerMerck KGaA
$113.00
+1.03%
as of 13 Apr
Power Core
Merck KGaA's moat is the irreplaceability of its Life Science consumables and process solutions embedded in regulated biopharmaceutical manufacturing workflows.
Direction of Movement
upward
MRK
Merck KGaA
$113.00
+1.03%
as of 13 Apr
DCF Fair Value: $128.69
Market data unavailable
Company Profile
Merck KGaA is a German multinational science and technology company headquartered in Darmstadt, founded in 1668 as the world's oldest operating chemical and pharmaceutical firm. It operates through three core business sectors: Healthcare, Life Science, and Electronics, employing around 60,000 people across 66 countries. In Healthcare, it develops therapies in oncology, immunology, neurology, and general medicine, with key products like Erbitux for cancer treatment and offerings in fertility and endocrinology. The Life Science division, bolstered by acquisitions such as Millipore in 2010 and Sigma-Aldrich in 2015, provides over 300,000 products including tools for bioprocessing, lab solutions, and research services under brands like MilliporeSigma. Electronics focuses on semiconductor materials, effect pigments for automotive and cosmetics, and advanced solutions for digital technologies. Merck KGaA drives innovation with major R&D centers in Darmstadt, Boston, Tokyo, and Beijing, emphasizing sustainable progress and scientific breakthroughs to address global challenges in health, research, and technology.